메뉴 건너뛰기
Turkish Journal of Gastroenterology
Volumn 21, Issue 2, 2010, Pages 197-198
Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma
Author keywords

[No Author keywords available]
Indexed keywords

BORTEZOMIB; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN LAMBDA CHAIN; LAMIVUDINE; STEROID; VINCRISTINE; VIRUS DNA;
EID: 77956905109     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0087     Document Type: Letter
Times cited : (17)
References (7)
  • 1
    • 34247520558 scopus 로고    scopus 로고
    • The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients
    • DOI 10.1002/ajh.20838
    • Tong Y, Qian J, Li Y, et al. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients. Am J Hematol 2007; 82: 403-4. (Pubitemid 46651148)
    • (2007) American Journal of Hematology , vol.82 , Issue.5 , pp. 403-404
    • Tong, Y.1    Qian, J.2    Li, Y.3    Meng, H.4    Jin, J.5
  • 2
    • 48649108472 scopus 로고    scopus 로고
    • Development of zona zoster during bortezomib treatment in patients with relapsed/refractory multiple myeloma
    • Ifran A, Beyan C, Kaptan K. Development of zona zoster during bortezomib treatment in patients with relapsed/refractory multiple myeloma. Turk J Hematol 2008; 25: 103-4.
    • (2008) Turk J Hematol , vol.25 , pp. 103-104
    • Ifran, A.1    Beyan, C.2    Kaptan, K.3
  • 3
    • 34249809423 scopus 로고    scopus 로고
    • Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitro
    • DOI 10.1016/j.leukres.2006.09.002, PII S0145212606003407
    • Orciuolo E, Galimberti S, Petrini M. Bortezomib inhibits Tcell function versus infective antigenic stimuli in a dose-dependent manner in vitro. Leuk Res 2007; 31: 1026-7. (Pubitemid 46856718)
    • (2007) Leukemia Research , vol.31 , Issue.7 , pp. 1026-1027
    • Orciuolo, E.1    Galimberti, S.2    Petrini, M.3
  • 4
    • 22544471559 scopus 로고    scopus 로고
    • Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice
    • Wu KL, Van Wieringen W, Vellenga E, et al. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice. Haematologica 2005; 90: 996-7. (Pubitemid 41020311)
    • (2005) Haematologica , vol.90 , Issue.7 , pp. 996-997
    • Wu, K.L.1    Van Wieringen, W.2    Vellenga, E.3    Zweegman, S.4    Lokhorst, H.M.5    Sonneveld, P.6
  • 5
    • 14044264214 scopus 로고    scopus 로고
    • Bortezomib-induced severe hepatitis in multiple myeloma: A case report
    • DOI 10.1001/archinte.165.4.464
    • Rosinol L, Montoto S, Ciberia MT, Blade J. Bortezomib-induced severe hepatitis in multiple myeloma. Arch Intern Med 2005; 165: 464-5. (Pubitemid 40280205)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.4 , pp. 464-465
    • Rosinol, L.1    Montoto, S.2    Cibeira, M.T.3    Blade, J.4
  • 6
    • 35348988646 scopus 로고    scopus 로고
    • Managing and avoiding bortezomib toxicity
    • Menashe J. Managing and avoiding bortezomib toxicity. Commun Oncol 2007; 4: 480-4.
    • (2007) Commun Oncol , vol.4 , pp. 480-484
    • Menashe, J.1
  • 7
    • 58949084483 scopus 로고    scopus 로고
    • Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy
    • Vickrey E, Allen S, Mehta J, Singhal S. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 2009; 115: 229-32.
    • (2009) Cancer , vol.115 , pp. 229-232
    • Vickrey, E.1    Allen, S.2    Mehta, J.3    Singhal, S.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.